These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4598846)

  • 21. Relation of beta-lactamase activity to antimicrobial susceptibility in Serratia marcescens.
    Tsang JC; Sansing GA; Miller MA
    Antimicrob Agents Chemother; 1975 Sep; 8(3):277-81. PubMed ID: 1101819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decrease in respiration activity related to prodigiosin synthesis in Serratia marcescens.
    Kobayashi N; Ichikawa Y
    Microbiol Immunol; 1985; 29(4):301-8. PubMed ID: 3894888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibiotic susceptibilities of Serratia marcescens and Enterobacter liquefaciens.
    Greenup P; Blazevic DJ
    Appl Microbiol; 1971 Sep; 22(3):309-14. PubMed ID: 4330312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro investigations on the action fosfomycin alone and in combination with other antibiotics on Pseudomonas aeruginosa and Serratia marcescens.
    Ullmann U; Lindemann B
    Arzneimittelforschung; 1980; 30(8):1247-9. PubMed ID: 6776966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antibmicrobial susceptibility of Serratia marcescens isolated from hospitalized patients in 2003 - 2005].
    Młynarczyk G; Młynarczyk A; Pupek J; Bilewska A; Luczak M
    Med Dosw Mikrobiol; 2007; 59(1):35-42. PubMed ID: 17601029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study on pathogenicity, drug sensitivity and pigment production of Serratia marcescens.
    Wu KH
    Taiwan Yi Xue Hui Za Zhi; 1976 Feb; 75(2):120-9. PubMed ID: 787472
    [No Abstract]   [Full Text] [Related]  

  • 27. The role of Serratia marcescens porins in antibiotic resistance.
    Ruiz N; Montero T; Hernandez-Borrell J; Viñas M
    Microb Drug Resist; 2003; 9(3):257-64. PubMed ID: 12959404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrobial susceptibility of clinical isolates of Serratia marcescens.
    Alvarez JS; Regueiro B; Garrido MJ
    Antimicrob Agents Chemother; 1979 Oct; 16(4):523-4. PubMed ID: 391150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serratia marcescens: a study of the sensitivity of British isolates to antibacterial agents and their combinations.
    Gray J; McGhie D; Ball AP
    J Antimicrob Chemother; 1978 Nov; 4(6):551-9. PubMed ID: 361679
    [No Abstract]   [Full Text] [Related]  

  • 30. Antibiotic resistance patterns of clinical isolates of Serratia marcescens.
    Cooksey RC; Bannister ER; Farrar WE
    Antimicrob Agents Chemother; 1975 Apr; 7(4):396-9. PubMed ID: 1096799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fatty acid profiles in pigmented and non-pigmented strains of S. marcescens.
    Pizzimenti FC; Nostro A; Marino A; Villari A; Verzera A; Trozzi A; Alonzo V
    New Microbiol; 1999 Apr; 22(2):91-8. PubMed ID: 10322607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The in vivo and in vitro potentiation of sulfamethoxazole by trimethoprim against strains of Serratia marcescens.
    Grunberg E; Beskid G; DeLorenzo WF; Cleeland R
    Int J Clin Pharmacol; 1973 Aug; 8(1):47-50. PubMed ID: 4580383
    [No Abstract]   [Full Text] [Related]  

  • 33. Cell surface hydrophobicity of pigmented and nonpigmented clinical Serratia marcescens strains.
    Rosenberg M; Blumberger Y; Judes H; Bar-Ness R; Rubinstein E; Mazor Y
    Infect Immun; 1986 Mar; 51(3):932-5. PubMed ID: 3512440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro sensitivity of hospital strains of Serratia marcescens to chemotherapeutic agents.
    Verbist L; Spaepen J; Vandepitte J
    Chemotherapy; 1976; 22(1):43-54. PubMed ID: 767065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pigments and antibiogram of transconjugants from nonpigmented mutants of Serratia marcescens.
    Qian HL; Feng JS; Tsang JC
    Microbios; 1982; 33(132):101-10. PubMed ID: 7050637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative studies on antibiotic susceptibility in Serratia marcescens].
    Gulino R; Modde H
    Schweiz Rundsch Med Prax; 1973 Apr; 62(14):428-31. PubMed ID: 4572075
    [No Abstract]   [Full Text] [Related]  

  • 37. Detection of Serratia outbreaks in hospital.
    Farmer JJ; Davis BR; Hickman FW; Presley DB; Bodey GP; Negut M; Bobo RA
    Lancet; 1976 Aug; 2(7983):455-9. PubMed ID: 73753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hospital infection due to Serratia marcescens and its sensitivity to antibiotics].
    Filloy L; Serrano D; Borjas E
    Bol Med Hosp Infant Mex; 1980; 37(5):871-7. PubMed ID: 7000092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exoenzymatic characteristics and sensitivity to chemotherapeutics of Serratia marcescens. Their importance in epidemiological investigation.
    Neguţ M
    Arch Roum Pathol Exp Microbiol; 1978; 37(3-4):377-88. PubMed ID: 395929
    [No Abstract]   [Full Text] [Related]  

  • 40. Multidrug resistance in Serratia marcescens and cloning of genes responsible for the resistance.
    Chen J; Lee EW; Kuroda T; Mizushima T; Tsuchiya T
    Biol Pharm Bull; 2003 Mar; 26(3):391-3. PubMed ID: 12612456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.